Press Releases
Cocrystal Pharma Announces Abstract Accepted for Poster Presentation at 26th International Symposium on Hepatitis C Virus and Related Viruses
Cocrystal Pharma to Present at the 2019 Cantor Global Healthcare Conference
Cocrystal Pharma Presents Positive Preclinical Data for CC-42344 at the Options X for the Control of Influenza Conference
Cocrystal Pharma Announces Abstract Accepted for Oral Presentation at the ISIRV: Options X for the Control of Influenza Conference
Cocrystal Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Cocrystal Pharma Commences Patient Enrollment for Hong Kong Phase 2a Study of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
Cocrystal Pharma Reports First Quarter 2019 Financial Results and Provides Corporate Update
Cocrystal Pharma Reports 2018 Financial Results and Provides Corporate Overview and Business Outlook
Cocrystal Pharma Announces Closing of Private Placement
